Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2019 | Story Ruan Bruwer | Photo Supplied
Kovsies Women Cross-Country Team Marné Mentz, Vicky Oelofse, and Channah du Plessis
Marné Mentz, Ts’epang Sello, and Tyler Beling played a huge role in Kovsies' cross-country champions win.

After coming within a whisker of claiming the title in 2018, the University of the Free State’s (UFS) runners ensured that the University Sports South Africa (USSA) cross-country trophy comes to Bloemfontein in 2019.

Kovsies are the new national student cross-country champions after they (men and women combined) won the USSA Championships in Nelspruit on Saturday, 21 September. Kovsies and the University of Johannesburg (UJ) both finished with three gold medals at the same event in 2018. UJ finished with nine overall medals compared to the eight (three gold, two silver, and three silver) of the UFS, who had to settle for second place. In 2017, the UFS finished third.

The Kovsie women’s team played a huge role in carrying the team to the top of the medal table, winning four golds. They won the 4 km and 10 km women’s team competitions as well as the road relay. The top three places by the runners of a university determined the team winner.

Marné Mentz UFS Cross-Country

Marné Mentz’s gold medal in the four-kilometre race at the
USSA Cross Country Championships helped the Kovsies
win the overall title.

Marné Mentz (first), Vicky Oelofse (fifth), and Channah du Plessis (sixth) dominated the four-kilometre race. In the 10 km, Ts’epang Sello (third), Tyler Beling (sixth), and Lizandré Mulder (seventh) did enough to ensure another gold for the Free State students. Mentz, Sello, and Beling jointly took first place in the road relay.

In the 10-km race for men, Kovsies came fifth, with Victor Makhabesela the best performer (finishing ninth). Pakiso Mthembu, one of the contenders for the medal who won the silver medal at the National Cross Country Championships two weeks before, had to withdraw after 7 km in the race due to an injury.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept